- $40.46bn
- $41.28bn
- $4.34bn
Brief: Illumina® Protein Prep Launches To Drive Greater Proteomic Insights For Improved Drug Discovery And Development
Factbox: Healthcare firms see growing activist investor involvement in the past year
Brief: Carl Icahn Raises Shared Share Stake In Centuri Holdings, Dissolves In Dana,Illumina
Timeline: Trump's trade war with China in 2025
U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Amazon, Appfolio
Illumina Inc reports results for the quarter ended June 30 - Earnings Summary
Illumina Q2 revenue falls 3%, but beats expectations
Brief: Illumina Enhances Flagship Assay To Accelerate Access To Comprehensive Tumor Profiling
U.S. STOCKS ON THE MOVE-Alphabet, Warner Music Group, GeneDx
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Canopy Growth
Citi flags uncertainty in life science sector as funding shifts and tariffs bite
U.S. STOCKS ON THE MOVE-FVCBankcorp, Venture Global, Boeing
Citi flags uncertainty on life science sector as funding shifts and tariffs bite
Brief: Illumina To Buy Somalogic For $350 Million Plus $75 Million In Milestones
Brief: Illumina Inc - Enters Stock Purchase Agreement With Standard Biotools
Brief: Illumina To Acquire Somalogic, Accelerating Its Proteomics Business
Brief: Standard BioTools Enters Strategic Sale Of SomaLogic To Illumina
U.S. RESEARCH ROUNDUP- Caseys General Stores, Illumina, Starbucks
Brief: Illumina Expands Clinical Oncology Portfolio Unlocking New Standard Of Care And Access To Precision Therapies